JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M006547200 on January 31, 2001

J. Biol. Chem., Vol. 276, Issue 20, 17156-17162, May 18, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/20/17156    most recent
M006547200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiteman, P.
Right arrow Articles by Handford, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteman, P.
Right arrow Articles by Handford, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A G1127S Change in Calcium-binding Epidermal Growth Factor-like Domain 13 of Human Fibrillin-1 Causes Short Range Conformational Effects*

Pat WhitemanDagger , Rachel S. Smallridge§||, Vroni KnottDagger , Jemima J. CordleDagger , A. Kristina Downing§**, and Penny A. HandfordDagger Dagger Dagger

From the Divisions of Dagger  Molecular and Cellular Biochemistry and § Structural Biology, Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, United Kingdom

Human fibrillin-1, an extracellular matrix glycoprotein, has a modular organization that includes 43 calcium-binding epidermal growth factor-like (cbEGF) domains arranged as multiple tandem repeats. A missense mutation that changes a highly conserved glycine to serine (G1127S) has been identified in cbEGF13, which results in a variant of Marfan syndrome, a connective tissue disease. Previous experiments on isolated cbEGF13 and a cbEGF13-14 pair indicated that the G1127S mutation caused defective folding of cbEGF13 but not cbEGF14. We have used limited proteolysis methods and two-dimensional NMR spectroscopy to identify the structural consequences of this mutation in a covalently linked cbEGF12-13 pair and a cbEGF12-14 triple domain construct. Protease digestion studies of the cbEGF12-13 G1127S mutant pair indicated that both cbEGF12 and 13 retained similar calcium binding properties and thus tertiary structure to the normal domain pair, because all identified cleavage sites showed calcium-dependent protection from proteolysis. However, small changes in the conformation of cbEGF13 G1127S, revealed by the presence of a new protease-sensitive site and comparative two-dimensional NOESY data, suggested that the fold of the mutant domain was not identical to the wild-type, but was native-like. Additional cleavage sites identified in cbEGF12-14 G1127S indicated further subtle changes within the mutant domain but not the flanking domains. We have concluded the following in this study. (i) Covalent linkage of cbEGF12 preserves the native-like fold of cbEGF13 G1127S and (ii) conformational effects introduced by G1127S are localized to cbEGF13. This study demonstrates that missense mutations in fibrillin-1 cbEGF domains can cause short range structural effects in addition to long range effects previously observed with a E1073K mutation in cbEGF12.


* This work was supported in part by the Wellcome Trust.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Members of the Oxford Centre for Molecular Sciences, which is funded by the MRC, BBSRC, and EPSRC.

|| Supported by the Medical Research Council and St. Johns College, Oxford.

** A Wellcome Trust Senior Fellow.

Dagger Dagger To whom correspondence should be addressed. Tel.: 44 0 1865 285347; Fax: 44 0 1865 275259; E-mail: penny@bioch.ox.ac.uk.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. Cordle, C. RedfieldZ, M. Stacey, P. A. van der Merwe, A. C. Willis, B. R. Champion, S. Hambleton, and P. A. Handford
Localization of the Delta-like-1-binding Site in Human Notch-1 and Its Modulation by Calcium Affinity
J. Biol. Chem., April 25, 2008; 283(17): 11785 - 11793.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Davis, P. A. Handford, and C. Redfield
The N1317H Substitution Associated with Leber Congenital Amaurosis Results in Impaired Interdomain Packing in Human CRB1 Epidermal Growth Factor-like (EGF) Domains
J. Biol. Chem., September 28, 2007; 282(39): 28807 - 28814.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Whiteman, A. C. Willis, A. Warner, J. Brown, C. Redfield, and P. A. Handford
Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1
Hum. Mol. Genet., April 15, 2007; 16(8): 907 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P N Robinson, E Arteaga-Solis, C Baldock, G Collod-Beroud, P Booms, A De Paepe, H C Dietz, G Guo, P A Handford, D P Judge, et al.
The molecular genetics of Marfan syndrome and related disorders
J. Med. Genet., October 1, 2006; 43(10): 769 - 787.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Y. Suk, S. Jensen, A. McGettrick, A. C. Willis, P. Whiteman, C. Redfield, and P. A. Handford
Structural Consequences of Cysteine Substitutions C1977Y and C1977R in Calcium-binding Epidermal Growth Factor-like Domain 30 of Human Fibrillin-1
J. Biol. Chem., December 3, 2004; 279(49): 51258 - 51265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Vollbrandt, K. Tiedemann, E. El-Hallous, G. Lin, J. Brinckmann, H. John, B. Batge, H. Notbohm, and D. P. Reinhardt
Consequences of Cysteine Mutations in Calcium-binding Epidermal Growth Factor Modules of Fibrillin-1
J. Biol. Chem., July 30, 2004; 279(31): 32924 - 32931.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Whiteman and P. A. Handford
Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders
Hum. Mol. Genet., April 1, 2003; 12(7): 727 - 737.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Smallridge, P. Whiteman, J. M. Werner, I. D. Campbell, P. A. Handford, and A. K. Downing
Solution Structure and Dynamics of a Calcium Binding Epidermal Growth Factor-like Domain Pair from the Neonatal Region of Human Fibrillin-1
J. Biol. Chem., March 28, 2003; 278(14): 12199 - 12206.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.